Compare Liquidia Corporation Common Stock (LQDA) vs Nova Ltd (NVMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Nova Ltd — how do they compare? Liquidia Corporation Common Stock trades at $33.47 (market cap $3.04B), while Nova Ltd trades at $328.83 (market cap $10.54B). The key difference: Nova Ltd is far larger — about 3.5× Liquidia Corporation Common Stock's market cap, and Nova Ltd is more actively traded (365,531 versus 21,111,778). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nova Ltd for 6 Days on average.
| LQDA | NVMI | |
|---|---|---|
Market Cap | $3.04B | $10.54B |
Volume | 21,111,778 | 365,531 |
Sector | Health | Technology |
52-Week High | $91.03 | $605.65 |
52-Week Low | $22.02 | $275.78 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.94B | $10.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NVMI trades at $342.37, up 0.58% on the day, with a bearish technical signal driven by moving averages but supported by strong fundamentals including a 28.84% net income margin and three consecutive quarterly earnings beats. The stock is positioned near its pivot point of $344, with immediate support at $336. Revenue growth is projected to increase from $881 million in 2025 to $937 million in 2026, though net cash flow turned negative in 2026.
The outlook remains positive given the 85.7% analyst buy rating and a consensus price target of $556.50, implying significant upside. Key risks include high valuation multiples like a P/E of 42.64 and negative cash flow trends, but the company's tool-of-record status in AI chip packaging provides a durable growth catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Nova Ltd
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →
